134 related articles for article (PubMed ID: 9721596)
1. Effects of nicotine on 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced depression of striatal dopamine content and spontaneous locomotor activity in C57 black mice.
Gao ZG; Cui WY; Zhang HT; Liu CG
Pharmacol Res; 1998 Aug; 38(2):101-6. PubMed ID: 9721596
[TBL] [Abstract][Full Text] [Related]
2. Behavioral and biochemical effects of nicotine in an MPTP-induced mouse model of Parkinson's disease.
Sershen H; Hashim A; Lajtha A
Pharmacol Biochem Behav; 1987 Oct; 28(2):299-303. PubMed ID: 3500479
[TBL] [Abstract][Full Text] [Related]
3. Effects of nicotine on hydroxyl free radical formation in vitro and on MPTP-induced neurotoxicity in vivo.
Ferger B; Spratt C; Earl CD; Teismann P; Oertel WH; Kuschinsky K
Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):351-9. PubMed ID: 9774223
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of riluzole on MPTP-induced depletion of dopamine and its metabolite content in mice.
Araki T; Kumagai T; Matsubara M; Ido T; Imai Y; Itoyama Y
Metab Brain Dis; 2000 Sep; 15(3):193-201. PubMed ID: 11206588
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of acute and chronic nicotine treatment on MPTP-(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse.
Janson AM; Fuxe K; Goldstein M
Clin Investig; 1992; 70(3-4):232-8. PubMed ID: 1521037
[TBL] [Abstract][Full Text] [Related]
6. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.
Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL
Neurotoxicology; 2004 Sep; 25(5):761-9. PubMed ID: 15288507
[TBL] [Abstract][Full Text] [Related]
7. Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system of C57/B1 mice.
Dluzen DE
Brain Res; 1996 Apr; 715(1-2):113-8. PubMed ID: 8739629
[TBL] [Abstract][Full Text] [Related]
8. Zonisamide increases dopamine turnover in the striatum of mice and common marmosets treated with MPTP.
Yabe H; Choudhury ME; Kubo M; Nishikawa N; Nagai M; Nomoto M
J Pharmacol Sci; 2009 May; 110(1):64-8. PubMed ID: 19403994
[TBL] [Abstract][Full Text] [Related]
9. Chronic administration of nicotine fails to alter the MPTP-induced neurotoxicity in mice.
Fung YK; Fiske LA; Lau YS
Gen Pharmacol; 1991; 22(4):669-72. PubMed ID: 1936899
[TBL] [Abstract][Full Text] [Related]
10. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of riluzole in MPTP-treated mice.
Araki T; Kumagai T; Tanaka K; Matsubara M; Kato H; Itoyama Y; Imai Y
Brain Res; 2001 Nov; 918(1-2):176-81. PubMed ID: 11684056
[TBL] [Abstract][Full Text] [Related]
12. Effects of acute administration of DA agonists on locomotor activity: MPTP versus neonatal intracerebroventricular 6-OHDA treatment.
Archer T; Palomo T; McArthur R; Fredriksson A
Neurotox Res; 2003; 5(1-2):95-110. PubMed ID: 12832225
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of talipexole and pramipexole on MPTP-induced dopamine reduction in the striatum of C57BL/6N mice.
Kitamura Y; Kohno Y; Nakazawa M; Nomura Y
Jpn J Pharmacol; 1997 May; 74(1):51-7. PubMed ID: 9195297
[TBL] [Abstract][Full Text] [Related]
14. Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice.
Parain K; Marchand V; Dumery B; Hirsch E
Brain Res; 2001 Feb; 890(2):347-50. PubMed ID: 11164803
[TBL] [Abstract][Full Text] [Related]
15. Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
Araki T; Muramatsu Y; Tanaka K; Matsubara M; Imai Y
Neurosci Lett; 2001 Oct; 312(1):50-4. PubMed ID: 11578843
[TBL] [Abstract][Full Text] [Related]
16. PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine], a new MAO-B inhibitor, attenuates MPTP-induced depletion of striatal dopamine levels in C57/BL6 mice.
Perez V; Unzeta M
Neurochem Int; 2003 Feb; 42(3):221-9. PubMed ID: 12427476
[TBL] [Abstract][Full Text] [Related]
17. Caffeine's neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice.
Xu K; Xu YH; Chen JF; Schwarzschild MA
Neurosci Lett; 2002 Mar; 322(1):13-6. PubMed ID: 11958832
[TBL] [Abstract][Full Text] [Related]
18. Increased susceptibility of G-protein coupled receptor 6 deficient mice to MPTP neurotoxicity.
Oeckl P; Ferger B
Neuroscience; 2016 Nov; 337():218-223. PubMed ID: 27651149
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
Clarke PB; Reuben M
Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
[TBL] [Abstract][Full Text] [Related]
20. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
Sirinathsinghji DJ; Heavens RP; McBride CS
Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
